Parachute Mitral Valve

Parachute mitral valve is a rare congenital heart defect characterized by the presence of a single papillary muscle or an abnormal fusion of the papillary muscles in the left ventricle. This anomaly alters the anatomy of the mitral valve, reducing the effectiveness of its opening and closing mechanism and leading to congenital mitral stenosis. The term "parachute" refers to the valve’s distinctive morphology, where the chordae tendineae converge towards a single point instead of distributing evenly across two separate papillary muscles.

Embryology and Pathogenesis

During fetal development, the mitral valve forms through the fusion of endocardial cushions and the separation of myocardial trabeculae, which give rise to the papillary muscles. If this process fails to occur correctly, the papillary muscles may remain fused or develop in a reduced number, resulting in the typical anomaly of the parachute mitral valve. The causes of this malformation are not entirely clear, but some mechanisms have been identified:

Abnormal development of papillary muscles: improper formation of myocardial trabeculae prevents normal separation of valvular structures.
Genetic mutations: frequently associated with Shone’s syndrome, a complex congenital malformation that also includes supravalvular mitral stenosis, aortic coarctation, and left ventricular outflow tract abnormalities.
Abnormal development of endocardial cushions: may alter the normal formation of the mitral valve apparatus.

Pathophysiology

The presence of a single papillary muscle results in an abnormal distribution of forces regulating mitral valve dynamics. This leads to an alteration of blood flow from the left ventricle, causing hemodynamic repercussions. In severe cases, mitral stenosis impairs left ventricular filling, increasing left atrial pressure and progressively leading to pulmonary congestion and left ventricular hypertrophy.

Clinical Manifestations

The clinical presentation of parachute mitral valve depends on the severity of the stenosis. In mild cases, the patient may remain asymptomatic for many years, with a heart murmur as the only sign of the condition. In moderate or severe cases, the following symptoms may occur:

Exertional dyspnea, due to the heart's reduced ability to maintain an adequate blood flow.
Early fatigue, related to the increased workload required to overcome the valvular obstruction.
Palpitations, often associated with atrial fibrillation secondary to left atrial dilation.
Signs of congestive heart failure, in more advanced cases.

In neonates and young children with severe forms, the condition may present early with tachypnea, feeding difficulties, and cyanosis due to insufficient blood oxygenation.

Diagnosis

The identification of parachute mitral valve relies on echocardiography, which is the first-line imaging technique to visualize the valve anomaly and assess the pressure gradient across the mitral valve. In more complex cases, transesophageal echocardiography can provide a more detailed view of the valve anatomy and chordae tendineae. Other diagnostic tools include:

Cardiac magnetic resonance imaging (CMR): useful for a three-dimensional evaluation of cardiac structures.
Cardiac catheterization: allows for precise hemodynamic measurements, especially in patients being considered for surgical correction.

Treatment

The therapeutic approach to parachute mitral valve depends on the severity of the stenosis and the patient’s symptoms. In mild cases, clinical monitoring may be sufficient, with regular check-ups to assess disease progression.
When stenosis becomes significant and symptoms appear, corrective intervention is necessary. Treatment options include:

Mitral valvuloplasty: a percutaneous or surgical procedure that improves blood flow through the mitral valve without requiring replacement.
Surgical valve repair: involves remodeling the chordae tendineae to redistribute forces more effectively across the valve.
Mitral valve replacement: in severe cases where valvuloplasty is not effective, a mechanical or biological prosthetic valve must be implanted.

Prognosis

The prognosis depends on the severity of mitral stenosis and the timing of intervention. In patients with mild forms, quality of life is generally good, with a stable clinical course over time. In moderate and severe cases, prognosis is closely related to early diagnosis and effective treatment. When treated early, surgery can ensure:

Excellent long-term survival, with significant symptom reduction.
Improved cardiac function, due to the removal of the mitral flow obstruction.
Prevention of secondary complications, such as pulmonary hypertension and heart failure.

However, long-term follow-up is essential to monitor for recurrent stenosis or the need for additional interventions.

Conclusion

Parachute mitral valve is a rare congenital anomaly that, in severe cases, can impair normal heart function and lead to heart failure. Early diagnosis, supported by echocardiography and advanced imaging techniques, allows for optimal management of the condition. In symptomatic patients, surgical treatment remains the only option to improve cardiac function and prevent long-term complications.

References

Vahanian A. et al. *2021 ESC/EACTS Guidelines for the management of valvular heart disease.* European Heart Journal, 43(7), 2022, pp. 561-632.
Blomström-Lundqvist C. et al. *ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias.* European Heart Journal, 24(20), 2003, pp. 1857-1897.
Colombo A. et al. *L’imaging multimodale nell’impianto transcatetere della valvola aortica: il ruolo fondamentale dell’ecocardiografia.* Giornale Italiano di Cardiologia, 12(10), 2011, pp. 652-663.
Chiti C. et al. *Prolasso valvolare mitralico e disgiunzione mitro-anulare: la consapevolezza di un possibile substrato aritmico.* Giornale Italiano di Cardiologia, 23(3), 2022, pp. 181-189.
Pugliese P. et al. *Chirurgia ricostruttiva delle valvole mitrale e tricuspide con anello flessibile di Cosgrove-Edwards.* Italian Heart Journal Supplement, 1(4), 2000, pp. 532-536.
David T. et al. *Congenital supravalvular mitral ring: surgical management and long-term outcomes.* Annals of Thoracic Surgery, 89(3), 2010, pp. 764-770.
Shoji H. et al. *Echocardiographic findings in supravalvular mitral ring: differentiation from mitral stenosis.* Journal of the American Society of Echocardiography, 15(8), 2002, pp. 915-921.
McElhinney D. et al. *Supravalvular mitral ring and Shone complex: diagnosis, treatment, and prognosis.* Pediatric Cardiology, 27(1), 2006, pp. 56-61.
Gaynor J. et al. *Congenital mitral valve anomalies: surgical outcomes and considerations.* Journal of Thoracic and Cardiovascular Surgery, 141(1), 2011, pp. 99-107.
Kumar K. et al. *Congenital mitral valve disorders: embryological considerations and current perspectives.* International Journal of Cardiology, 268(1), 2018, pp. 102-108.